In June 2026, Integra LifeSciences Holdings announced a reshaped commercial leadership team, including new executives to ...

The acquisition will become part of Integra’s Codman Specialty Surgical (CSS) division. The ear, nose and throat (ENT) category is a key area of strategic interest and highly complementary to the ...

Integra LifeSciences Holdings Corporation (NASDAQ:IART) agreed to acquire Acclarent Inc. from Ethicon Inc, a Johnson & Johnson (NYSE:JNJ) MedTech company, for $275 million in cash, and an additional ...

Integra LifeSciences specializes in neuro-related surgical devices and regenerative tissue technologies. Read why IART stock ...

Jan De Witte to retire as CEO by the end of 2024Stuart Essig appointed executive chairman of the Board “We are grateful to Jan for his leadership and commitment to Integra and the role he has played ...

Medical device company Integra LifeSciences (NASDAQ:IART) reported Q2 CY2025 results , but sales were flat year on year at $415.6 million. The company expects next quarter’s revenue to be around $415 ...

PRINCETON, N.J., June 15, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Bob Davis, executive vice ...

PRINCETON, N.J., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (IART) (Nasdaq:IART) today announced the appointment of Dr. Raymond Turner as its new corporate vice ...

Medical device company Integra LifeSciences (NASDAQ:IART) will be reporting results this Thursday before market open. Here’s what to look for. Integra LifeSciences met analysts’ revenue expectations ...